Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial (Q33186857)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 1, 2003

Language	Label	Description	Also known as
English	Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial	scientific article published on May 1, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial (English)

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

phase II clinical trial

0 references

multicenter clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721251

28 December 2023

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Anastase Spiliopoulos

11

object named as

Anastase Spiliopoulos

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

7

object named as

Ralph A. Schmid

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721251

28 December 2023

author name string

Shu-Fang Hsu Schmitz

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Martin Tötsch

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Eva Hansen

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Christine Joss

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Christian von Briel

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Miklos Pless

8

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

James Habicht

9

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Rolf Stahel

12

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Walter Weder

13

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Roger Stupp

14

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Fritz Egli

15

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Markus Furrer

16

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Hanspeter Honegger

17

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Martin Wernli

18

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Thomas Cerny

19

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Hans-Beat Ris

20

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Daniel C. Betticher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721251

28 December 2023

Arnaud D. Roth

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721251

28 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

full work available at URL

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.11.040

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1752-1759

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Preoperative chemotherapy for non-small cell lung cancer

2

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study

3

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis

4

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

5

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

6

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

8

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

10

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.

11

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy

13

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Pneumonectomy for malignant disease: factors affecting early morbidity and mortality

14

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Preoperative chemotherapy for lung cancer does not increase surgical morbidity

15

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Induction chemotherapy before surgery for early-stage lung cancer: A novel approach

16

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Postoperative complications after combined neoadjuvant treatment of lung cancer

18

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

19

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer

20

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients

22

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

23

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial

24

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

25

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival

26

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

27

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group

28

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

29

1 reference

10.1200/JCO.2003.11.040

https://api.crossref.org/works/10.1200/JCO.2003.11.040

28 December 2023

Identifiers

10.1200/JCO.2003.11.040

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33186857&oldid=2265515337"